Back to top

India

Firm

Deal

Value

Client

Lawyer(s) involved

AZB & Partners

Issue of non- convertible debentures by Porbandar Solar Power Limited

$19.3 million

Yes Bank Limited, India Infrastructure Finance Company Limited, Asian Development Bank

Gautam Saha (Partner)

 

Ambarish Mohanty,  Pallavi Meena (Associates)

AZB & Partners

Dr. Lal PathLabs Limited’s IPO of up to 11,600,000 equity shares

$99 million

WestBridge Crossover Fund, Sanjeevini Investment Holdings

Madhurima Mukherjee

(Partner)

 

Namita Das, Akshita Shrivastva

(Associates)

AZB & Partners

Acquisition of additional stake in Locon Solutions Private Limited by SoftBank

 

SoftBank affiliate SIMI Pacific II Pte. Ltd

Srinath Dasari, Nanditha Gopal

(Partners)

AZB & Partners

Acquisition of 27% equity stake by Agfa HealthCare in MphRx USA

 

Mphrx India

Zia Mody, Rushabh Maniar, Nandan Pendsey

(Partners)

 

Veena Dsouza, Sneha Nagvekar (Associates)

AZB & Partners

Floreat Investments’ issuance of unsecured unlisted rated redeemable non-convertible debentures

$31 million

Axis Bank Limited

Anand Shah

(Partner)

 

Ashutosh Narang

(Associate)

AZB & Partners

IFC and ADV’s acquisition of equity stake in Encore Asset Reconstruction Company Private Limited

 

International Finance Corporation, Asia Growth Investment Holdings Pte. Limited

Gautam Saha (Partner)

 

Dushyant Bagga, Heena Singh (Associate)

AZB & Partners

Acquisition of an additional 23.3% equity stake by Munich Health Holding AG of Apollo Munich Health Insurance

$26 million

Munich Re Group

Rajendra Barot (Partner)

 

Arvind Ramesh, Rishikesh Desai

(Associates)

Baker & Hostetler

Venaxis’ transaction with Strand Life Sciences

 

Strand Life Sciences

 

Ballard Spahr

Venaxis’ transaction with Strand Life Sciences

 

Venaxis, Inc

 

Cyril Amarchand Mangaldas

Acquisition by HCL Technologies of 100% stake in Point to Point Limited and Point to Point Products Limited

 

HCL Technologies Limited

Harsh Kumar

(Partner)

Cyril Amarchand Mangaldas

Disinvestment in Engineers India Limited by the President of India

 

Department of Disinvestment, Ministry of Finance, Government of India

Cyril Shroff, Aarti Joshi, Gokul Rajan

(Partners)

 

DLA Piper

Acquisition by HCL Technologies of 100% stake in Point to Point Limited and Point to Point Products Limited

 

HCL Technologies Limited

 

Herbert Smith Freehills

Disinvestment in Engineers India Limited by the President of India

 

Department of Disinvestment, Ministry of Finance, Government of India

 

Jones Day

Disinvestment in Engineers India Limited by the President of India

 

Brokers

 

Khaitan & Co

ADV Partners’ investment in Dr Agarwal’s Health Care

Approx. $45 million

Dr. Agarwal’s Health Care Limited

Kartick Maheshwari

(Associate Partner)

 

Deepak Jodhani (Senior Associate)

 

Radhika Agarwal, Nikita Appaswami

(Associates)

Khaitan & Co

National Payment Corporation of India’s private placement of equity shares

$20 million

National Payment Corporation of India

Sudhir Bassi (Executive Director)

 

Madhur Kohli (Associate Partner)

 

Aanchal Arora, Manish Chhangani, Nisarg Shah, Harsh Zaveri

(Associates)

Khaitan & Co

Firstsource’s acquisition BPO business of ISG Novasoft and ISGN Corp

$13 million

Firstsource

Ashish Razdan

(Partner)

 

Pooja Patel

(Principal Associate)

 

Kapish Mandhyan, Pavi Jain, Siddhant Bhatt

(Associates)

Latham & Watkins

Ctrip’s investment in MakeMyTrip

$180 million

MakeMyTrip Limited

Rajiv Gupta, Posit Laohaphan, Jiyeon Lee-Lim, William Lu

(Partners)

 

Dipti Thakar, Louis Rabinowitz

(Counsel)

 

Francesca Rothkell, Bora Bozkurt

(Associates)

Majmudar & Partners

Venaxis’ transaction with Strand Life Sciences

 

Venaxis, Inc.

Rukshad Davar

(Partner)

Nishith Desai Associates

Nspira Management Services Private Limited’s round of investment

$60 million

Nspira Management Services Private Limited

 

Orbis Partners

Acquisition by HCL Technologies of 100% stake in Point to Point Limited and Point to Point Products Limited

 

Point to Point Limited and Point to Point Products Limited

 

Shardul Amarchand Mangaldas

Disinvestment in Engineers India Limited by the President of India

 

Brokers

 

Trilegal

Strand Life Sciences Private Limited’s  acquisition of a majority stake in Venaxis, Inc

 

Strand Life Sciences Private Limited

Kosturi Ghosh

(Partner)

 

Ipsita Chowdhury, Vallishree Chandra, Radhika Sarkar

(Associates)

Trilegal

Venaxis’ transaction with Strand Life Sciences

 

Strand Life Sciences

 

Wragge Lawrence Graham & Co

Acquisition by HCL Technologies of 100% stake in Point to Point Limited and Point to Point Products Limited

 

Point to Point Limited and Point to Point Products Limited

Baljit Chohan

(Partner)

 

Back to top

Malaysia

Firm

Deal

Value

Client

Lawyer(s) involved

Wong & Partners

Sistem Televisyen Malaysia’s joint venture with CJ O Shopping establish a JV

RM 65 million

($15 million)

Sistem Televisyen Malaysia Berhad

Munir Abdul Aziz

(Partner)

 

Yee Weng Lim, Yen May Low

(Associates)

Back to top

Singapore

Firm

Deal

Value

Client

Lawyer(s) involved

Colin Ng & Partners

SUTL Enterprise Limited’s sale of its equity stake in Achieva Technology Pte. Ltd

S$2.4 million

($1.6 million)

SUTL Enterprise Limited

Lisa Theng, Ken Chia

(Partners)

 

Joshua Khng (Associate)

Back to top

Related Articles

CAM cap marks partner jumps to AZB

by Nimitt Dixit |

India’s capital markets partner musical chairs have continued with Cyril Amarchand Mangaldas partner Janhavi Seksaria moving down the street to AZB & Partners in Mumbai, at a time when law firms look to bolster their practices to align with India’s unprecedented stock market run in 2024.

AZB, STB act on OYO’s $525 mln U.S. bet

by Nimitt Dixit |

AZB & Partners has acted for Oravel Stays, the parent of e-hotelier OYO, on its proposed $525 million acquisition of U.S. motel operator G6 Hospitality from PE fund Blackstone. Simpson Thacher & Bartlett acted for Blackstone on the deal.

AZB, Khaitan guide Mankind’s $1.6 bln biopharma deal

by Nimitt Dixit |

AZB & Partners has served as legal advisor to Mankind Pharma on its agreement to acquire Bharat Serums and Vaccines (BSV) for 136.3 billion rupees ($1.6 billion) from private equity firm Advent International, which has been guided by Khaitan & Co.